Profile
Lyndsey Scull worked as a Director of Corporate Communications at Magenta Therapeutics, Inc. from 2019 to 2021.
Former positions of Lyndsey Scull
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 2021-09-30 |
Experiences
Positions held
Connections
17
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Lyndsey Scull
